Sammaan Capital Limited is launching a Rights Issue price of Rs 150 Per share (50 already Paid), available for subscription from 08 August 2024 to 22 August 2024.
The first and final call money is Rs 100. The first call money issue size is 24,62,62,515. They own it as of the record date, 22 July 2024. Each share has a face value of Rs. 2 at a ratio of 1:2 premium of 148.
Stay tuned with us for comprehensive details on Sammaan Capital Limited's 2024 Rights Issue, including the issue size, entitlement, payment terms, and more.
Corporate Action | |
---|---|
Security Name | Sammaan Capital Ltd |
Issue Open/Close | 08 Aug 2024 to 22 Aug 2024 |
Record Date | JULY 22, 2024 |
First Call Money Issue Size (Shares) | 24,62,26,515 |
First & Final Call Money | ₹100 |
Right Issue Price | ₹150 per share (50 Already Paid) |
Face Value | ₹2.00 |
Terms of Payment | Call Notice for First and Final Call Money of Rs 100.00 (comprising of Rs 1.33 towards face value and Rs 98.67 towards Securities Premium) per Partly Paid-up Equity Share of the Company Sammaan Capital Ltd (Formerly known as Indiabulls Housing Finance Ltd)] |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.